About
Therapies for autoimmune neuropsychiatric diseases
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodySan Diego & Southern California
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
70
By Phase
PHASE1: 2
By Status
ACTIVE_NOT_RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06753955Lead Sponsor
Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy Participants
PHASE1Active, not recruiting
6 participants
Started: Mar 18, 2025 · Completed: Dec 24, 2025
NCT06575153Lead Sponsor
Phase 1 Study of ART5803 in Healthy Participants
PHASE1Active, not recruiting
64 participants
Started: Sep 10, 2024 · Completed: Apr 8, 2026
Locations (1)
Headquarters
La Jolla, CA, United States
Map
Loading map...